Indication
For the treatment of adult patients with idiopathic pulmonary fibrosis (IPF).
Medicine details
- Medicine name:
- nerandomilast (Jascayd)
- SMC ID:
- SMC2991
- Pharmaceutical company
- Boehringer Ingelheim Ltd
- BNF chapter
- Respiratory system
- Submission type
- Full
- Publication due date:
- 22 October 2026
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC